13087 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Levine
    Levine
  4. Zelenetz
    Zelenetz
  5. Horwitz
    Horwitz
  6. Abdel-Wahab
    Abdel-Wahab
  7. Scheinberg
    Scheinberg
  8. Jakubowski
    Jakubowski
  9. Landau
    Landau
  10. Shah
    Shah

Groups

  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)
  7. Lymphoma (2639)
  8. Sloan Kettering Institute Faculty (2602)
  9. Executive Committee, Center for Hematologic Malignancies (2358)
  10. Survivorship Research (2328)
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An update of safety and efficacy results from phase 1 dose-escalation and expansion study of vodobatinib, a novel oral BCR-ABL1 tyrosine kinase inhibitor (TKI), in patients with chronic myeloid leukemia (CML) and philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) failing prior TKI therapies
    Meeting Abstract

    Cortes, J. E.; Saikia, T.; Kim, D. W.; Alvarado, Y.; Nicolini, F. E.; Rathnam, K.; Khattry, N.; Apperley, J. F.; Deininger, M. W.; de Lavallade, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Radiation therapy for patients with diffuse large B cell Richter's syndrome of CLL
    Meeting Abstract

    Sacchi De Camargo Correia, G.; Imber, B. S.; Hajj, C.; Thompson, M. C.; Mato, A. R.; Yahalom, J.; Roeker, L. E.
    Blood (2021)

    Fulltext@MSK | Save
  • Impaired RAS proteolysis drives clonal hematopoietic transformation
    Meeting Abstract

    Chen, S.; Vedula, R. S.; Castel, P.; Cuevas Navarro, A.; Hogg, S. J.; Wang, E.; Mi, X.; Benbarche, S.; Knorr, K.; Kim, W. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of autologous hematopoietic cell transplant (HCT) followed by dendritic cell/myeloma fusion vaccine with lenalidomide maintenance in increasing multiple myeloma (MM) immunity (BMT CTN 1401)
    Meeting Abstract

    Chung, D. J.; Shah, N.; Stroopinsky, D.; Wu, J.; Bisharat, L.; Callander, N. S.; Logan, B. R.; Anderson, K. C.; Chodon, T.; Mohan, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Synergism between CAR-T cells and a personalized tumor vaccine in hematological malignances
    Meeting Abstract

    Cheloni, G.; Capelletti, M.; Torres, D.; Bindal, P.; Liegel, J. J.; Stroopinsky, D.; Bisharat, L.; Rahimian, M.; Yoo, S. Y.; Hauser, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Non-relapse mortality in TP53-mutated MDS/AML - A multi-center collaborative study
    Meeting Abstract

    Byrne, M. T.; Kurian, T. J.; Patel, D. A.; Tamari, R.; Hong, S.; Abdelhakim, H.; Klein, V.; Rojas, P.; Madhavan, R.; Kent, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy is an effective and well-tolerated treatment option for patients with relapsed/refractory (R/R) follicular lymphoma (FL) who have received ≥ 2 prior lines of therapy: Pivotal results from a phase I/II study
    Meeting Abstract

    Budde, L. E.; Sehn, L. H.; Matasar, M. J.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of entospletinib in combination with intensive induction and consolidation chemotherapy in adults with newly diagnosed nucleophosmin 1-mutated acute myeloid leukemia
    Meeting Abstract

    Byrd, J. C.; Cortes, J. E.; Minden, M. D.; Oellerich, T.; Stein, E. M.; Elder, J.; Kumar, P.; Bray, G.; DiMartino, J.; Stock, W.
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 1 dose escalation study of IGM-2323, a novel anti-CD20 x anti-CD3 IgM T cell engager (TCE) in patients with advanced B-cell malignancies
    Meeting Abstract

    Budde, E.; Gopal, A. K.; Kim, W. S.; Flinn, I. W.; Cheah, C. Y. Y.; Nastoupil, L.; Matasar, M. J.; Diefenbach, C. S.; Gregory, G. P.; Qazi, I.; more...
    Blood (2021)

    Fulltext@MSK | Save